TY - JOUR
T1 - Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants
AU - Banho, Cecília Artico
AU - de Carvalho Marques, Beatriz
AU - Sacchetto, Lívia
AU - Lima, Ana Karoline Sepedro
AU - Parra, Maisa Carla Pereira
AU - Lima, Alex Ranieri Jeronimo
AU - Ribeiro, Gabriela
AU - Martins, Antonio Jorge
AU - Barros, Claudia Renata dos Santos
AU - Elias, Maria Carolina
AU - Sampaio, Sandra Coccuzzo
AU - Slavov, Svetoslav Nanev
AU - Rodrigues, Evandra Strazza
AU - Santos, Elaine Vieira
AU - Covas, Dimas Tadeu
AU - Kashima, Simone
AU - Brassaloti, Ricardo Augusto
AU - Petry, Bruna
AU - Clemente, Luan Gaspar
AU - Coutinho, Luiz Lehmann
AU - Assato, Patricia Akemi
AU - da Silva da Costa, Felipe Allan
AU - Grotto, Rejane Maria Tommasini
AU - Poleti, Mirele Daiana
AU - Lesbon, Jessika Cristina Chagas
AU - Mattos, Elisangela Chicaroni
AU - Fukumasu, Heidge
AU - Giovanetti, Marta
AU - Alcantara, Luiz Carlos Junior
AU - Souza-Neto, Jayme A.
AU - Rahal, Paula
AU - Araújo, João Pessoa
AU - Spilki, Fernando Rosado
AU - Althouse, Benjamin M.
AU - Vasilakis, Nikos
AU - Nogueira, Maurício Lacerda
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Since 2021, the emergence of variants of concern (VOC) has led Brazil to experience record numbers of in COVID-19 cases and deaths. The expanded spread of the SARS-CoV-2 combined with a low vaccination rate has contributed to the emergence of new mutations that may enhance viral fitness, leading to the persistence of the disease. Due to limitations in the real-time genomic monitoring of new variants in some Brazilian states, we aimed to investigate whether genomic surveillance, coupled with epidemiological data and SARS-CoV-2 variants spatiotemporal spread in a smaller region, can reflect the pandemic progression at a national level. Our findings revealed three SARS-CoV-2 variant replacements from 2021 to early 2022, corresponding to the introduction and increase in the frequency of Gamma, Delta, and Omicron variants, as indicated by peaks of the Effective Reproductive Number (Reff). These distinct clade replacements triggered two waves of COVID-19 cases, influenced by the increasing vaccine uptake over time. Our results indicated that the effectiveness of vaccination in preventing new cases during the Delta and Omicron circulations was six and eleven times higher, respectively, than during the period when Gamma was predominant, and it was highly efficient in reducing the number of deaths. Furthermore, we demonstrated that genomic monitoring at a local level can reflect the national trends in the spread and evolution of SARS-CoV-2.
AB - Since 2021, the emergence of variants of concern (VOC) has led Brazil to experience record numbers of in COVID-19 cases and deaths. The expanded spread of the SARS-CoV-2 combined with a low vaccination rate has contributed to the emergence of new mutations that may enhance viral fitness, leading to the persistence of the disease. Due to limitations in the real-time genomic monitoring of new variants in some Brazilian states, we aimed to investigate whether genomic surveillance, coupled with epidemiological data and SARS-CoV-2 variants spatiotemporal spread in a smaller region, can reflect the pandemic progression at a national level. Our findings revealed three SARS-CoV-2 variant replacements from 2021 to early 2022, corresponding to the introduction and increase in the frequency of Gamma, Delta, and Omicron variants, as indicated by peaks of the Effective Reproductive Number (Reff). These distinct clade replacements triggered two waves of COVID-19 cases, influenced by the increasing vaccine uptake over time. Our results indicated that the effectiveness of vaccination in preventing new cases during the Delta and Omicron circulations was six and eleven times higher, respectively, than during the period when Gamma was predominant, and it was highly efficient in reducing the number of deaths. Furthermore, we demonstrated that genomic monitoring at a local level can reflect the national trends in the spread and evolution of SARS-CoV-2.
UR - http://www.scopus.com/inward/record.url?scp=85200838607&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85200838607&partnerID=8YFLogxK
U2 - 10.1038/s41541-024-00933-w
DO - 10.1038/s41541-024-00933-w
M3 - Article
C2 - 39127725
AN - SCOPUS:85200838607
SN - 2059-0105
VL - 9
JO - npj Vaccines
JF - npj Vaccines
IS - 1
M1 - 145
ER -